Extension of clinical trial matching capabilities to mobile application expands the ways Genospace customers can take action on genomic and clinical data
CAMBRIDGE, MA — October 25, 2016 — Genospace, a leading data analytics platform serving the healthcare and life sciences industry, today announced the launch of Genospace Trial Match. The newly launched mobile application enables real-time clinical trial matching at the point of care based on molecular profiling and clinical data.
“Matching patients to clinical trials in a timely fashion has been an inefficient and challenging process for many healthcare organizations,” said Mick Correll, CEO of Genospace. “Our offerings have matched tens of thousands of patients to clinical trials and helped their physicians develop optimal therapeutic strategies. We are extremely proud to deliver real-time clinical trials matches directly to the clinical teams of our health care provider customers.”
The Genospace clinical trial matching app allows leaders in precision medicine to streamline the clinical trial matching process by identifying patients who may qualify for open and enrolling clinical trials. Trial Match automatically updates patient trial matches as new EMR, molecular, or clinical trial information is added at the enterprise level. Clinicians then receive push notifications on their phone and can take action to facilitate trial enrollment. The accompanying trial coordinator portal provides a system-wide view of all patients and trials, along with the ability to track all trial matches and referrals being made via the app.
At Genospace, our mission is to deliver the platform that makes biomedical data useful and usable by everyone. Genospace has built a comprehensive platform for precision medicine to enable interpretation, analysis, reporting and collaboration on high-dimensional genomic and other biomedical data. With specific applications supporting research, development, pathology and clinical care, many of the most advanced precision medicine organizations are powered by Genospace. Please visit www.genospace.com for more information.